BIO-TECHNE Corp
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 3, 2026 (8 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 13, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | — | 54% |
| Jul 9, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| Jun 30, 2026 | TD Cowen | downgrade | Buy → Hold | — | 54% |
| Jun 30, 2026 | Benchmark | downgrade | Buy → Hold | — | 54% |
| Jun 29, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| Jun 26, 2026 | Stephens & Co. | downgrade | Overweight → Equal-Weight | — | 54% |
| Jun 26, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Jun 26, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jun 11, 2026 | Piper Sandler | initiate | — → Neutral | — | 54% |
| May 7, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 7, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Apr 6, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Feb 6, 2026 | Wells Fargo | maintain | Overweight → Overweight | $76 | 54% |
| Feb 5, 2026 | Citigroup | maintain | Buy → Buy | $80 | 54% |
| Feb 5, 2026 | Stifel | maintain | Hold → Hold | $65 | 53% |
| Feb 5, 2026 | TD Cowen | maintain | Buy → Buy | $80 | 54% |
| Feb 5, 2026 | UBS | maintain | Buy → Buy | $79 | 54% |
| Feb 5, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $68 | 58% |
| Jan 5, 2026 | Evercore ISI Group | downgrade | Outperform → In-Line | $62 | 58% |
| Nov 20, 2025 | Argus Research | maintain | Buy → Buy | $68 | 53% |
| Nov 6, 2025 | UBS | maintain | Buy → Buy | $70 | 54% |
| Nov 6, 2025 | Wells Fargo | maintain | Overweight → Overweight | $70 | 54% |
| Oct 14, 2025 | TD Cowen | maintain | Buy → Buy | $70 | 54% |
| Oct 7, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $72 | 58% |
| Sep 3, 2025 | RBC Capital | upgrade | Sector Perform → Outperform | $73 | 55% |
| Aug 21, 2025 | Citigroup | upgrade | Neutral → Buy | $70 | 54% |
| Aug 7, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $61 | 55% |
| Jul 11, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $75 | 55% |
| Jul 9, 2025 | TD Cowen | initiate | — → Buy | $65 | 54% |
| Jun 5, 2025 | Benchmark | reiterate | Buy → Buy | $75 | 54% |
| May 30, 2025 | Wells Fargo | initiate | — → Overweight | $59 | 54% |
| May 9, 2025 | UBS | maintain | Buy → Buy | $70 | 54% |
| May 8, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $63 | 55% |
| May 8, 2025 | Benchmark | maintain | Buy → Buy | $75 | 54% |
| May 8, 2025 | Stifel | maintain | Hold → Hold | $60 | 53% |
| Apr 9, 2025 | Keybanc | downgrade | Overweight → Sector Weight | $0 | 53% |
| Apr 8, 2025 | Keybanc | downgrade | Overweight → Sector Weight | $0 | 53% |
| Mar 18, 2025 | Evercore ISI Group | initiate | — → Outperform | $75 | 58% |
| Mar 4, 2025 | Citigroup | maintain | Neutral → Neutral | $70 | 54% |
| Feb 19, 2025 | Baird | downgrade | Outperform → Neutral | $68 | 55% |
| Feb 6, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $80 | 55% |
| Feb 6, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $90 | 55% |
| Feb 6, 2025 | Keybanc | maintain | Overweight → Overweight | $90 | 53% |
| Feb 6, 2025 | Baird | maintain | Outperform → Outperform | $88 | 55% |
| Oct 31, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $88 | 55% |
| Oct 31, 2024 | Baird | maintain | Outperform → Outperform | $84 | 55% |
| Aug 13, 2024 | Benchmark | reiterate | Buy → Buy | $95 | 54% |
| Aug 8, 2024 | RBC Capital | maintain | Sector Perform → Sector Perform | $70 | 55% |
| Aug 8, 2024 | Baird | maintain | Outperform → Outperform | $82 | 55% |
No cross-platform signals in the last 90 days